| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,837 |
10,214 |
$804K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,168 |
7,604 |
$435K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,220 |
1,206 |
$115K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
802 |
799 |
$68K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
451 |
440 |
$47K |
| 90756 |
|
856 |
847 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,869 |
1,564 |
$16K |
| 99215 |
Prolong outpt/office vis |
130 |
125 |
$12K |
| 93000 |
|
1,171 |
1,154 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,398 |
1,373 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
111 |
111 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
861 |
857 |
$8K |
| 81002 |
|
2,089 |
2,041 |
$5K |
| 99406 |
|
405 |
394 |
$3K |
| 96160 |
|
223 |
223 |
$3K |
| 96127 |
|
994 |
990 |
$3K |
| 99442 |
|
146 |
135 |
$2K |
| 99205 |
Prolong outpt/office vis |
15 |
15 |
$2K |
| 90661 |
|
54 |
53 |
$2K |
| 94010 |
|
60 |
56 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
171 |
156 |
$918.22 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
456 |
424 |
$712.84 |
| 99441 |
|
100 |
92 |
$682.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
49 |
47 |
$549.13 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
17 |
$537.64 |
| 81025 |
|
76 |
76 |
$537.31 |
| 90715 |
|
12 |
12 |
$374.76 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26 |
24 |
$317.53 |
| 81003 |
|
205 |
202 |
$298.07 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
20 |
19 |
$171.42 |
| 99000 |
|
13 |
12 |
$117.71 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
12 |
$30.58 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,044 |
1,028 |
$20.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
75 |
67 |
$0.50 |
| 3074F |
|
2,986 |
2,848 |
$0.26 |
| 3078F |
|
2,552 |
2,449 |
$0.23 |
| 3079F |
|
1,786 |
1,728 |
$0.18 |
| 3008F |
|
2,356 |
2,244 |
$0.14 |
| 3075F |
|
843 |
820 |
$0.11 |
| 3077F |
|
95 |
91 |
$0.03 |
| 1159F |
|
825 |
799 |
$0.02 |
| 1160F |
|
1,213 |
1,160 |
$0.02 |
| 4037F |
|
723 |
718 |
$0.02 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,758 |
2,401 |
$0.00 |
| 3725F |
|
805 |
793 |
$0.00 |
| 3288F |
|
25 |
25 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,533 |
1,510 |
$0.00 |
| 4035F |
|
52 |
51 |
$0.00 |
| 1036F |
|
1,606 |
1,525 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,315 |
1,295 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
320 |
297 |
$0.00 |
| 3044F |
|
421 |
413 |
$0.00 |
| 1035F |
|
124 |
114 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
103 |
96 |
$0.00 |
| 1126F |
|
1,100 |
1,065 |
$0.00 |
| 1034F |
|
1,112 |
1,062 |
$0.00 |
| 1125F |
|
1,093 |
1,042 |
$0.00 |
| 90694 |
|
12 |
12 |
$0.00 |